Albuterol Sulfate Patent Expiration
Albuterol Sulfate was first introduced by Schering Corp Sub Schering Plough Corp
Albuterol Sulfate Patents
Given below is the list of patents protecting Albuterol Sulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Accuneb | US6702997 | Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
Dec 28, 2021
(Expired) | Mylan Speciality Lp |
| Proair Digihaler | US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof | May 18, 2031 | Teva Branded Pharm |
| Proair Digihaler | US10124131 | Dose counter for inhaler having an anti-reverse rotation actuator | May 18, 2031 | Teva Branded Pharm |
| Proair Digihaler | US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator | Jan 01, 2032 | Teva Branded Pharm |
| Proair Digihaler | US10569034 | Compliance monitoring module for a breath-actuated inhaler | Aug 16, 2036 | Teva Branded Pharm |
| Proair Digihaler | US10765820 | Dry powder inhalation apparatus | May 19, 2025 | Teva Branded Pharm |
| Proair Digihaler | US10918816 | Compliance monitoring module for a breath-actuated inhaler | Dec 14, 2035 | Teva Branded Pharm |
| Proair Digihaler | US11000653 | Inhaler | Dec 18, 2038 | Teva Branded Pharm |
| Proair Digihaler | US11173259 | Drug delivery device with electronics and power management | Jul 06, 2040 | Teva Branded Pharm |
| Proair Digihaler | US11266796 | Inhalation device with integrated electronics | Feb 22, 2041 | Teva Branded Pharm |
| Proair Digihaler | US11344685 | Drug delivery device with electronics | Sep 26, 2039 | Teva Branded Pharm |
| Proair Digihaler | US11351317 | Drug delivery device with electronics | Feb 10, 2038 | Teva Branded Pharm |
| Proair Digihaler | US11357935 | Drug delivery device with electronics | Sep 24, 2038 | Teva Branded Pharm |
| Proair Digihaler | US11439777 | Drug delivery device with electronics | May 24, 2040 | Teva Branded Pharm |
| Proair Digihaler | US11464923 | Inhaler system | Jun 19, 2040 | Teva Branded Pharm |
| Proair Digihaler | US6701917 | Dose counter for medicament inhaler |
Jun 23, 2021
(Expired) | Teva Branded Pharm |
| Proair Digihaler | US6718972 | Dose metering system for medicament inhaler |
Jun 23, 2021
(Expired) | Teva Branded Pharm |
| Proair Digihaler | US6748947 | De-agglomerator for breath-actuated dry powder inhaler |
Jun 23, 2021
(Expired) | Teva Branded Pharm |
| Proair Digihaler | US6871646 | De-agglomerator for breath-actuated dry powder inhaler |
Jun 23, 2021
(Expired) | Teva Branded Pharm |
| Proair Digihaler | US7540282 | Reservoir pressure system for medicament inhaler |
May 06, 2023
(Expired) | Teva Branded Pharm |
| Proair Digihaler | US8006690 | Reservoir pressure system for medicament inhaler |
Jun 23, 2021
(Expired) | Teva Branded Pharm |
| Proair Digihaler | US8651103 | Dry powder inhalation apparatus | Mar 26, 2028 | Teva Branded Pharm |
| Proair Digihaler | US8978966 | Dose counters for inhalers, inhalers and methods of assembly thereof | Jan 13, 2032 | Teva Branded Pharm |
| Proair Digihaler | US9216260 | Dose counters for inhalers, inhalers and methods of assembly thereof | Jun 28, 2031 | Teva Branded Pharm |
| Proair Digihaler | US9463288 | Dry powder inhalation apparatus | May 19, 2025 | Teva Branded Pharm |
| Proair Digihaler | US9731087 | Dose counter for inhaler having a bore and shaft arrangement | May 18, 2031 | Teva Branded Pharm |
| Proair Digihaler | US9782550 | Compliance monitoring module for a breath-actuated inhaler | Aug 28, 2035 | Teva Branded Pharm |
| Proair Digihaler | US9782551 | Compliance monitoring module for a breath-actuated inhaler | Aug 28, 2035 | Teva Branded Pharm |
| Proair Hfa | US10022509 | Dose counter for inhaler having a bore and shaft arrangement | May 18, 2031 | Teva Branded Pharm |
| Proair Hfa | US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof | May 18, 2031 | Teva Branded Pharm |
| Proair Hfa | US10086156 | Dose counter for inhaler and method for counting doses | May 18, 2031 | Teva Branded Pharm |
| Proair Hfa | US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator | Jan 01, 2032 | Teva Branded Pharm |
| Proair Hfa | US10695512 | Dose counter for inhaler having an anti-reverse rotation actuator | May 18, 2031 | Teva Branded Pharm |
| Proair Hfa | US11395889 | Dose counter for inhaler having an anti-reverse rotation actuator | May 18, 2031 | Teva Branded Pharm |
| Proair Hfa | US5605674 | Medicinal aerosol formulations |
Feb 25, 2014
(Expired) | Teva Branded Pharm |
| Proair Hfa | US6446627 | Inhaler dose counter |
Dec 18, 2017
(Expired) | Teva Branded Pharm |
| Proair Hfa | US7105152 | Suspension aerosol formulations |
Sep 12, 2023
(Expired) | Teva Branded Pharm |
| Proair Hfa | US7566445 | Medicinal aerosols and methods of delivery thereof |
Jun 04, 2017
(Expired) | Teva Branded Pharm |
| Proair Hfa | US8132712 | Metered-dose inhaler | Sep 07, 2028 | Teva Branded Pharm |
| Proair Hfa | US8834849 | Medicinal aerosols and methods of delivery thereof |
Jun 04, 2017
(Expired) | Teva Branded Pharm |
| Proair Hfa | US9463289 | Dose counters for inhalers, inhalers and methods of assembly thereof | May 18, 2031 | Teva Branded Pharm |
| Proair Hfa | US9808587 | Dose counter for inhaler having an anti-reverse rotation actuator | May 18, 2031 | Teva Branded Pharm |
| Proair Respiclick | US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof | May 18, 2031 | Teva Branded Pharm |
| Proair Respiclick | US10124131 | Dose counter for inhaler having an anti-reverse rotation actuator | May 18, 2031 | Teva Branded Pharm |
| Proair Respiclick | US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator | Jan 01, 2032 | Teva Branded Pharm |
| Proair Respiclick | US10765820 | Dry powder inhalation apparatus | May 19, 2025 | Teva Branded Pharm |
| Proair Respiclick | US6446627 | Inhaler dose counter |
Dec 18, 2017
(Expired) | Teva Branded Pharm |
| Proair Respiclick | US6701917 | Dose counter for medicament inhaler |
Jun 23, 2021
(Expired) | Teva Branded Pharm |
| Proair Respiclick | US6718972 | Dose metering system for medicament inhaler |
Jun 23, 2021
(Expired) | Teva Branded Pharm |
| Proair Respiclick | US6748947 | De-agglomerator for breath-actuated dry powder inhaler |
Jun 23, 2021
(Expired) | Teva Branded Pharm |
| Proair Respiclick | US6871646 | De-agglomerator for breath-actuated dry powder inhaler |
Jun 23, 2021
(Expired) | Teva Branded Pharm |
| Proair Respiclick | US7540282 | Reservoir pressure system for medicament inhaler |
May 06, 2023
(Expired) | Teva Branded Pharm |
| Proair Respiclick | US8006690 | Reservoir pressure system for medicament inhaler |
Jun 23, 2021
(Expired) | Teva Branded Pharm |
| Proair Respiclick | US8651103 | Dry powder inhalation apparatus | Mar 26, 2028 | Teva Branded Pharm |
| Proair Respiclick | US8978966 | Dose counters for inhalers, inhalers and methods of assembly thereof | Jan 13, 2032 | Teva Branded Pharm |
| Proair Respiclick | US9216260 | Dose counters for inhalers, inhalers and methods of assembly thereof | Jun 28, 2031 | Teva Branded Pharm |
| Proair Respiclick | US9463288 | Dry powder inhalation apparatus | May 19, 2025 | Teva Branded Pharm |
| Proair Respiclick | US9731087 | Dose counter for inhaler having a bore and shaft arrangement | May 18, 2031 | Teva Branded Pharm |
| Proair Respiclick | US9782550 | Compliance monitoring module for a breath-actuated inhaler | Aug 28, 2035 | Teva Branded Pharm |
| Proair Respiclick | US9782551 | Compliance monitoring module for a breath-actuated inhaler | Aug 28, 2035 | Teva Branded Pharm |
| Proventil-hfa | US5605674 | Medicinal aerosol formulations |
Feb 25, 2014
(Expired) | Kindeva |
| Proventil-hfa | US5775321 | Seal configuration for aerosol canister |
Jul 07, 2015
(Expired) | Kindeva |
| Proventil-hfa | US6006745 | Device for delivering an aerosol |
Dec 28, 2016
(Expired) | Kindeva |
| Ventolin Hfa | US6161724 | Indicating device |
Jan 16, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US6161724 (Pediatric) | Indicating device |
Jul 16, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US6170717 | Valve for aerosol container |
Dec 23, 2017
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US6170717 (Pediatric) | Valve for aerosol container |
Jun 23, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US6315173 | Valve for aerosol container |
Dec 23, 2017
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US6315173 (Pediatric) | Valve for aerosol container |
Jun 23, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US6431168 | Dispenser with doses′ counter |
Jun 08, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US6431168 (Pediatric) | Dispenser with doses′ counter |
Dec 08, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US6435372 | Delivery system for a medicament and method for the assembly thereof |
Jan 16, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US6435372 (Pediatric) | Delivery system for a medicament and method for the assembly thereof |
Jul 16, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US6510969 | Valve for aerosol container |
Dec 23, 2017
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US6510969 (Pediatric) | Valve for aerosol container |
Jun 23, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US6558651 | Aerosols containing annealed particulate salbutamol and tetrafluoroethane |
Dec 19, 2016
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US6558651 (Pediatric) | Aerosols containing annealed particulate salbutamol and tetrafluoroethane |
Jun 19, 2017
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US6596260 | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
Aug 10, 2014
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US6596260 (Pediatric) | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
Feb 10, 2015
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US6743413 | Suspension aerosol formulations |
Jun 01, 2021
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US6743413 (Pediatric) | Suspension aerosol formulations |
Dec 01, 2021
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US6938796 | Indicating device |
Jan 16, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US6938796 (Pediatric) | Indicating device |
Jul 16, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US6966467 | Valve for aerosol container |
Dec 23, 2017
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US6966467 (Pediatric) | Valve for aerosol container |
Jun 23, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US6997349 | Indicating device |
Jan 16, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US6997349 (Pediatric) | Indicating device |
Jul 16, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US7107986 | Dispenser with doses' counter |
Jun 08, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US7107986 (Pediatric) | Dispenser with doses' counter |
Dec 06, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US7143908 | Indicating device |
Jan 16, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US7143908 (Pediatric) | Indicating device |
Jul 16, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US7350676 | Valve for aerosol container |
Aug 24, 2018
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US7350676 (Pediatric) | Valve for aerosol container |
Feb 24, 2019
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US7500444 | Actuation indicator for a dispensing device | Jan 04, 2025 | Glaxosmithkline |
| Ventolin Hfa |
US7500444 (Pediatric) | Actuation indicator for a dispensing device | Jul 04, 2025 | Glaxosmithkline |
| Ventolin Hfa | US7832351 | Actuation indicator for a dispensing device |
Jun 19, 2023
(Expired) | Glaxosmithkline |
| Ventolin Hfa |
US7832351 (Pediatric) | Actuation indicator for a dispensing device |
Dec 19, 2023
(Expired) | Glaxosmithkline |
| Ventolin Hfa | US9861771 | Device housing for an aerosol container |
Oct 11, 2020
(Expired) | Glaxosmithkline |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Albuterol Sulfate Generics
Several generic applications have been filed for Albuterol Sulfate. The first generic version for Albuterol Sulfate was by Sandoz Inc and was approved on Dec 5, 1989. And the latest generic version is by Armstrong Pharmaceuticals Inc and was approved on May 21, 2024.
Given below is the list of companies who have filed for Albuterol Sulfate generic.
1. WOCKHARDT EU OPERATN
Wockhardt Eu Operations Swiss Ag has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Wockhardt Eu Operatn.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE | solution | Discontinued | INHALATION | N/A | Nov 22, 1999 |
2. LUPIN
Lupin Inc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Lupin.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.09MG BASE/INH | aerosol, metered | Prescription | INHALATION | AB2 | Aug 24, 2020 |
3. LANDELA PHARM
Landela Pharmaceutical has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Landela Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE | solution | Discontinued | INHALATION | N/A | Apr 4, 2006 |
4. VIRTUS PHARM
Virtus Pharmaceutical Inc has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Virtus Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Prescription | ORAL | AB | Oct 26, 2018 |
| EQ 4MG BASE | tablet | Prescription | ORAL | AB | Oct 26, 2018 |
5. APOTEX INC
Apotex Inc has filed for 4 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Apotex Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5% BASE | solution | Discontinued | INHALATION | N/A | Apr 1, 2003 |
| EQ 0.083% BASE | solution | Discontinued | INHALATION | N/A | Feb 2, 2007 |
| EQ 0.021% BASE | solution | Discontinued | INHALATION | N/A | Apr 5, 2010 |
| EQ 0.042% BASE | solution | Discontinued | INHALATION | N/A | Apr 5, 2010 |
6. TEVA
Teva Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Teva.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | Jun 25, 1993 |
| EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | Jun 25, 1993 |
| EQ 2MG BASE/5ML
(reference standard) | syrup | Prescription | ORAL | AA | Mar 30, 1992 |
7. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 3 different strengths of generic version for Albuterol Sulfate. Out of these eq 4mg base version comes by the name VOSPIRE ER, eq 8mg base version comes by the name VOSPIRE ER. Given below are the details of the strengths of this generic introduced by Strides Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | Dec 20, 1989 |
| EQ 4MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Sep 26, 2002 |
| EQ 8MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Sep 26, 2002 |
8. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | solution | Discontinued | INHALATION | N/A | Feb 21, 1992 |
9. UCB INC
Ucb Inc has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Ucb Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | Sep 29, 1992 |
| EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | Sep 29, 1992 |
10. COSETTE
Cosette Pharmaceuticals Inc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Cosette.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE/5ML | syrup | Prescription | ORAL | AA | Sep 25, 1995 |
11. AMNEAL PHARMS
Amneal Pharmaceuticals has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Amneal Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE/5ML | syrup | Prescription | ORAL | AA | May 12, 2010 |
12. WATSON LABS INC
Watson Laboratories Inc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE | solution | Discontinued | INHALATION | N/A | Nov 24, 2003 |
13. QUAGEN
Quagen Pharmaceuticals Llc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Quagen.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE/5ML | syrup | Prescription | ORAL | AA | Sep 6, 2019 |
14. CIPLA
Cipla Ltd has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.09MG BASE/INH | aerosol, metered | Prescription | INHALATION | AB1 | Apr 8, 2020 |
15. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE/5ML | syrup | Discontinued | ORAL | N/A | Jan 30, 1998 |
16. AM THERAP
American Therapeutics Inc has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Am Therap.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | Dec 5, 1989 |
| EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | Dec 5, 1989 |
17. DASH PHARMS NATCO
Dash Pharmaceuticals Llc A Fully Owned Sub Of Natco Pharma Ltd has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Dash Pharms Natco.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Prescription | ORAL | AB | Jan 17, 1991 |
| EQ 4MG BASE
(reference standard) | tablet | Prescription | ORAL | AB | Jan 17, 1991 |
18. WATSON LABS
Watson Laboratories Inc has filed for 5 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Watson Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | Aug 28, 1991 |
| EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | Aug 28, 1991 |
| EQ 2MG BASE/5ML | syrup | Discontinued | ORAL | N/A | Apr 29, 1993 |
| EQ 0.042% BASE | solution | Discontinued | INHALATION | N/A | Sep 25, 2007 |
| EQ 0.021% BASE | solution | Discontinued | INHALATION | N/A | Sep 25, 2007 |
19. LUOXIN AUROVITAS
Luoxin Aurovitas Pharma Chengdu Co Ltd has filed for 3 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Luoxin Aurovitas.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE | solution | Prescription | INHALATION | AN | Oct 17, 2017 |
| EQ 0.042% BASE | solution | Prescription | INHALATION | AN | Apr 20, 2020 |
| EQ 0.021% BASE | solution | Prescription | INHALATION | AN | Apr 20, 2020 |
20. PLIVA
Pliva Inc has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Pliva.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | Dec 5, 1989 |
| EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | Dec 5, 1989 |
21. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Prescription | ORAL | AB | Oct 22, 2020 |
| EQ 4MG BASE | tablet | Prescription | ORAL | AB | Oct 22, 2020 |
22. RITEDOSE CORP
The Ritedose Corp has filed for 3 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Ritedose Corp.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE | solution | Prescription | INHALATION | AN | Dec 16, 2008 |
| EQ 0.021% BASE
(reference standard) | solution | Prescription | INHALATION | AN | Dec 28, 2021 |
| EQ 0.042% BASE | solution | Prescription | INHALATION | AN | Dec 28, 2021 |
23. AMNEAL PHARMS CO
Amneal Pharmaceuticals Co Gmbh has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Amneal Pharms Co.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4MG BASE | tablet | Prescription | ORAL | AB | May 21, 2018 |
| EQ 2MG BASE | tablet | Prescription | ORAL | AB | May 21, 2018 |
24. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 3 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | Dec 5, 1989 |
| EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | Dec 5, 1989 |
| EQ 2MG BASE/5ML | syrup | Prescription | ORAL | AA | Jun 26, 2007 |
25. ROXANE
Roxane Laboratories Inc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Roxane.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE | solution | Discontinued | INHALATION | N/A | Feb 13, 2001 |
26. SANDOZ
Sandoz Inc has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Sandoz.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | Dec 5, 1989 |
| EQ 0.09MG BASE/INH | aerosol, metered | Prescription | INHALATION | AB1 | Jun 1, 2021 |
27. BAUSCH
Bausch Health Us Llc has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Bausch.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5% BASE | solution | Discontinued | INHALATION | N/A | Jun 18, 1998 |
| EQ 0.083% BASE | solution | Discontinued | INHALATION | N/A | Mar 29, 2000 |
28. SUN PHARM INDUSTRIES
Sun Pharmaceutical Industries Inc has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4MG BASE | tablet | Prescription | ORAL | AB | Dec 5, 1989 |
| EQ 2MG BASE | tablet | Prescription | ORAL | AB | Dec 5, 1989 |
29. SENTISS
Sentiss Ag has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Sentiss.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5% BASE | solution | Prescription | INHALATION | AN | Jan 15, 1998 |
30. NEPHRON
Nephron Pharmaceuticals Corp has filed for 4 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Nephron.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE
(reference standard) | solution | Prescription | INHALATION | AN | Sep 17, 1997 |
| EQ 0.5% BASE
(reference standard) | solution | Prescription | INHALATION | AN | Jun 26, 2001 |
| EQ 0.042% BASE
(reference standard) | solution | Prescription | INHALATION | AN | Jun 28, 2004 |
| EQ 0.021% BASE | solution | Prescription | INHALATION | AN | Mar 31, 2010 |
31. DAVA PHARMS INC
Dava Pharmaceuticals Inc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Dava Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | Dec 20, 1989 |
32. EYWA
Eywa Pharma Inc has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Eywa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | Oct 8, 2020 |
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | Oct 8, 2020 |
33. COPLEY PHARM
Copley Pharmaceutical Inc has filed for 4 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Copley Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | Nov 22, 1991 |
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | Nov 22, 1991 |
| EQ 0.5% BASE | solution | Discontinued | INHALATION | N/A | Nov 27, 1991 |
| EQ 0.083% BASE | solution | Discontinued | INHALATION | N/A | May 28, 1993 |
34. MOVA
Mova Pharmaceuticals Corp has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Mova.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE/5ML | syrup | Discontinued | ORAL | N/A | Sep 30, 1994 |
35. RISING
Rising Pharma Holdings Inc has filed for 3 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 4MG BASE | tablet | Prescription | ORAL | AB | Jun 29, 2018 |
| EQ 8MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Jan 29, 2007 |
| EQ 2MG BASE | tablet | Prescription | ORAL | AB | Jun 29, 2018 |
36. ACTAVIS MID ATLANTIC
Actavis Mid Atlantic Llc has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Actavis Mid Atlantic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE | solution | Discontinued | INHALATION | N/A | Sep 26, 1995 |
| EQ 2MG BASE/5ML | syrup | Discontinued | ORAL | N/A | Mar 30, 1999 |
37. CHARTWELL MOLECULAR
Chartwell Molecular Holdings Llc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE/5ML | syrup | Prescription | ORAL | AA | Dec 27, 2006 |
38. TEVA PHARMS
Teva Pharmaceuticals Usa has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Teva Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE | solution | Discontinued | INHALATION | N/A | Nov 9, 1999 |
39. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | May 14, 2020 |
| EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | May 14, 2020 |
40. WARNER CHILCOTT
Warner Chilcott Div Warner Lambert Co has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Warner Chilcott.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | Jan 9, 1990 |
| EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | Jan 9, 1990 |
41. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE | solution | Prescription | INHALATION | AN | Jul 21, 2017 |
42. LEXENPHARM
Lexenpharm Suzhou Ltd has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Lexenpharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.021% BASE | solution | Prescription | INHALATION | AN | May 3, 2024 |
| EQ 0.042% BASE | solution | Prescription | INHALATION | AN | May 3, 2024 |
43. EPIC PHARMA LLC
Epic Pharma Llc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.083% BASE | solution | Discontinued | INHALATION | N/A | Feb 9, 1999 |
44. ARMSTRONG PHARMS
Armstrong Pharmaceuticals Inc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Armstrong Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.09MG BASE/INH | aerosol, metered | Prescription | INHALATION | AB2 | May 21, 2024 |
45. PADAGIS US
Padagis Us Llc has filed for 1 generic for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Padagis Us.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.09MG BASE/INH | aerosol, metered | Discontinued | INHALATION | N/A | Feb 24, 2020 |
46. AIZANT
Aizant Drug Research Solutions Private Ltd has filed for 2 different strengths of generic version for Albuterol Sulfate. Given below are the details of the strengths of this generic introduced by Aizant.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 2MG BASE | tablet | Prescription | ORAL | BX | Mar 15, 2019 |
| EQ 4MG BASE | tablet | Prescription | ORAL | BX | Mar 15, 2019 |